CoChat

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group

Thriemer, Kamala, Ley, Benedikt, Bobogare, Albino, Dysoley, Lek, Alam, Mohammad Shafiul, Pasaribu, Ayodhia P., Sattabongkot, Jetsumon, Jambert, Elodie, Domingo, Gonzalo J., Commons, Robert, Auburn, Sarah, Marfurt, Jutta, Devine, Angela, Aktaruzzaman, Mohammad M., Sohel, Nayeem, Namgay, Rinzin, Drukpa, Tobgyel, Sharma, Surender Nath, Sarawati, Elvieda, Samad, Iriani, Theodora, Minerva, Nambanya, Simone, Ounekham, Sonesay, Mudin, Rose Nanti Binti, Da Thakur, Garib, Makita, Leo Sora, Deray, Raffy, Lee, Sang-Eun, Boaz, Leonard, Danansuriya, Manjula N., Mudiyanselage, Santha D., Chinanonwait, Nipon, Kitchakarn, Suravadee, Nausien, Johnny, Naket, Esau, Duc, Thang Ngo, Do Manh, Ha, Hong, Young S., Cheng, Qin, Richards, Jack S., Kusriastuti, Rita, Satyagraha, Ari, Noviyanti, Rintis, Ding, Xavier C., Khan, Wasif Ali, Swe Phru, Ching, Guoding, Zhu, Qi, Gao, Kaneko, Akira, Miotto, Olivo, Nguitragool, Wang, Roobsoong, Wanlapa, Battle, Katherine, Howes, Rosalind E., Roca-Feltrer, Arantxa, Duparc, Stephan, Bhowmick, Ipsita Pal, Kenangalem, Enny, Bibit, Jo-Anne, Barry, Alyssa, Sintasath, David, Abeyasinghe, Rabindra, Sibley, Carol H., McCarthy, James, von Seidlein, Lorenz, Baird, J. Kevin, Price, Ric N. · 2017 · Malaria Journal
Cited by 76

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12936-017-1784-1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 51

  1. Baird JK. Neglect of Plasmodium vivax malaria. Trends Parasitol. 2007;23:533–9. · DOI · Paper page
  2. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti Elyazar I, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg. 2007;77:984–91. · DOI · Paper page
  3. RBM. The Asia Pacific Malaria Elimination Network (APMEN) supporting the common goal of a malaria-free Asia Pacific (Progress & impact series, 11). Geneva: Roll Back Malaria Parternship Secreteriat; 2014.
  4. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112. · DOI · Paper page
  5. Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malar J. 2015;14:377. · doi:10.1186/s12936-015-0896-8
  6. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74. · DOI · Paper page
  7. WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.
  8. Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, et al. Perceptions of P. vivax malaria and barriers to routine G6PD testing prior to its treatment with primaquine. Malar J. 2017. (under review). · DOI
  9. Vivax Working Group. Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group. Malar J. 2015;14:484. · DOI · Paper page
  10. Recht J, Ashley E, White NJ. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization; 2014.
  11. Monteiro WM, Moura-Neto JP, Recht J, Bassat Q, Lacerda MV. Fatal primaquine-induced hemolysis in a patient with Plasmodium vivax malaria and G6PD A(-) variant in the Brazilian Amazon. Clin Infect Dis. 2016;62:1188. · DOI · Paper page
  12. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418. · DOI · Paper page
  13. Beutler E, Duparc S. G6PD deficiency working group. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77:779–89. · DOI · Paper page
  14. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297. · DOI · Paper page
  15. Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135. · DOI · Paper page
  16. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430–5. · DOI · Paper page
  17. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science. 2009;326:1546–9. · DOI · Paper page
  18. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, et al. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med. 2010;7:e1000283. · DOI · Paper page
  19. IMPROV Study Group. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens. BMC Infect Dis. 2015;15:558. · DOI · Paper page
  20. Devine A, Parmiter M, Chu C, Bancone G, Nosten F, Price RN et al. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: a cost-effectiveness analysis. PLoS Neglect Trop Dis. Under review. 2017. · DOI
  21. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ. 2007;334:403. · DOI · Paper page
  22. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA. 2007;297:2227–31. · DOI · Paper page
  23. Uzochukwu BS, Onwujekwe E, Ezuma NN, Ezeoke OP, Ajuba MO, Sibeudu FT. Improving rational treatment of malaria: perceptions and influence of RDTs on prescribing behaviour of health workers in southeast Nigeria. PLoS ONE. 2011;6:e14627. · DOI
  24. Okebe JU, Walther B, Bojang K, Drammeh S, Schellenberg D, Conway DJ, et al. Prescribing practice for malaria following introduction of artemether–lumefantrine in an urban area with declining endemicity in West Africa. Malar J. 2010;9:180. · DOI
  25. Juma E, Zurovac D. Changes in health workers’ malaria diagnosis and treatment practices in Kenya. Malar J. 2011;10:1. · DOI · Paper page
  26. Msellem MI, Martensson A, Rotllant G, Bhattarai A, Stromberg J, Kahigwa E, et al. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study. PLoS Med. 2009;6:e1000070. · DOI · Paper page
  27. Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, et al. Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS ONE. 2011;6:e18419. · DOI · Paper page
  28. Skarbinski J, Ouma PO, Causer LM, Kariuki SK, Barnwell JW, Alaii JA, et al. Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether–lumefantrine in Kenya: a cluster randomized trial. Am J Trop Med Hyg. 2009;80:919–26. · DOI · Paper page
  29. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391. · DOI · Paper page
  30. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049–58. · DOI · Paper page
  31. Brito MA, Peixoto HM, Almeida AC, Oliveira MR, Romero GA, Moura-Neto JP, et al. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:446–55. · doi:10.1590/0037-8682-0134-2016
  32. Espino FE, Bibit JA, Sornillo JB, Tan A, von Seidlein L, Ley B. Comparison of three screening test kits for G6PD enzyme deficiency: implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the Philippines. PLoS ONE. 2016;11:e0148172. · DOI · Paper page
  33. Henriques G, Raut S, Phommasone K, Adhikari B, Pongvongsa T, Ley B, et al. Prevalence of glucose-6-phosphote dehydrogenase deficiency among a rural and remote population of Lao PDR (Laos). Atlanta: ASTMH Annual Meeting; 2016.
  34. Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015;165:677–88. · DOI · Paper page
  35. Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al. Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural eastern Indonesia. PLoS Neglect Trop Dis. 2016;10:e0004457. · DOI · Paper page
  36. Ley B, Alam MS, O’Donnell JJ, Hossain MS, Kibria MG, Jahan N, et al. A comparison of three quantitative methods to estimate G6PD activity in the Chittagong Hill tracts, Bangladesh. PLoS ONE. 2017;12:e0169930. · DOI
  37. Pereira EA, Ishikawa EA, Fontes CJ. Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region. Malar J. 2011;10:355. · DOI · Paper page
  38. Maneeboonyang W, Lawpoolsri S, Puangsa-Art S, Yimsamran S, Thanyavanich N, Wuthisen P, et al. Directly observed therapy with primaquine to reduce the recurrence rate of Plasmodium vivax infection along the Thai-Myanmar border. Southeast Asian J Trop Med Public Health. 2011;42:9–18.
  39. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308. · DOI
  40. Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko MA, Suwonkerd W. Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand. J Health Popul Nutr. 2009;27:4–13. · DOI · Paper page
  41. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, et al. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg. 2010;82:1017–23. · DOI
  42. Leslie T, Rab MA, Ahmadzai H, Durrani N, Fayaz M, Kolaczinski J, et al. Compliance with 14-day primaquine therapy for radical cure of vivax malaria–a randomized placebo-controlled trial comparing unsupervised with supervised treatment. Trans R Soc Trop Med Hyg. 2004;98:168–73. · DOI · Paper page
  43. Mohammed S, Glennerster R, Khan AJ. Impact of a daily SMS medication reminder system on tuberculosis treatment outcomes: a randomized controlled trial. PLoS ONE. 2016;11:e0162944. · DOI · Paper page
  44. Nsagha DS, Lange I, Fon PN, Nguedia Assob JC, Tanue EA. A randomized controlled trial on the usefulness of mobile text phone messages to improve the quality of care of HIV and AIDS patients in Cameroon. Open AIDS J. 2016;10:93–103. · DOI
  45. Talisuna AO, Oburu A, Githinji S, Malinga J, Amboko B, Bejon P, et al. Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial. Malar J. 2017;16:46. · DOI
  46. Githinji S, Jones C, Malinga J, Snow RW, Talisuna A, Zurovac D. Development of a text-messaging intervention to improve treatment adherence and post-treatment review of children with uncomplicated malaria in western Kenya. Malar J. 2015;14:320. · DOI
  47. Haase J, Farris KB, Dorsch MP. Mobile applications to improve medication adherence. Telemed J E Health. 2017;23:75–9. · DOI · Paper page
  48. Price RN, Nosten F. Single-dose radical cure of Plasmodium vivax: a step closer. Lancet. 2014;383:1020–1. · doi:10.1016/s0140-6736(13)62672-0
  49. Travis SF, Kumar SP, Paez PC, Delivoria-Papadopoulos M. Red cell metabolic alterations in postnatal life in term infants: glycolytic enzymes and glucose-6-phosphate dehydrogenase. Pediatr Res. 1980;14:1349–52. · doi:10.1203/00006450-198012000-00016
  50. Konrad PN, Valentine WN, Paglia DE. Enzymatic activities and glutathione content of erythrocytes in the newborn: comparison with red cells of older normal subjects and those with comparable reticulocytosis. Acta Haematol. 1972;48:193–201. · doi:10.1159/000208458
  51. WHO. World Malaria Report. Geneva. Switzerland: World Health Organization; 2015. p. 2015.

Cited by

See all 76

Metadata

Authors
Thriemer, K., Ley, B., Bobogare, A., Dysoley, L., Alam, M. S., Pasaribu, A. P., Sattabongkot, J., Jambert, E., Domingo, G. J., Commons, R., Auburn, S., Marfurt, J., Devine, A., Aktaruzzaman, M. M., Sohel, N., Namgay, R., Drukpa, T., Sharma, S. N., Sarawati, E., Samad, I., Theodora, M., Nambanya, S., Ounekham, S., Mudin, R. N. B., Da Thakur, G., Makita, L. S., Deray, R., Lee, S.-E., Boaz, L., Danansuriya, M. N., Mudiyanselage, S. D., Chinanonwait, N., Kitchakarn, S., Nausien, J., Naket, E., Duc, T. N., Do Manh, H., Hong, Y. S., Cheng, Q., Richards, J. S., Kusriastuti, R., Satyagraha, A., Noviyanti, R., Ding, X. C., Khan, W. A., Swe Phru, C., Guoding, Z., Qi, G., Kaneko, A., Miotto, O., Nguitragool, W., Roobsoong, W., Battle, K., Howes, R. E., Roca-Feltrer, A., Duparc, S., Bhowmick, I. P., Kenangalem, E., Bibit, J.-A., Barry, A., Sintasath, D., Abeyasinghe, R., Sibley, C. H., McCarthy, J., von Seidlein, L., Baird, J. K., & Price, R. N.
Venue
Malaria Journal
Published
2017-04-05
Volume
16
Issue
1
ISSN
1475-2875
Cited by
76
References
3
Language
en
Licence
Funders
Bill & Melinda Gates Foundation (OPP1164105)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. https://app.cochat.ai/papers/10.1186/s12936-017-1784-1
The paper
Thriemer, K., Ley, B., Bobogare, A., Dysoley, L., Alam, M. S., Pasaribu, A. P., Sattabongkot, J., Jambert, E., Domingo, G. J., Commons, R., Auburn, S., Marfurt, J., Devine, A., Aktaruzzaman, M. M., Sohel, N., Namgay, R., Drukpa, T., Sharma, S. N., Sarawati, E., . . . Price, R. N. (2017). Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malaria Journal. https://doi.org/10.1186/s12936-017-1784-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.